Innovation in cardiovascular drugs: drug development portfolios. 3-4 March 1999, London, UK.
This conference, organized by SMi, brought together representatives from some of the leading companies in cardiovascular (CV) drug development. The two-day meeting was chaired by Dr Ajay Kakkar (Thrombosis Research Institute, London, UK) and covered drug development portfolios, genetic approaches to therapy and innovative therapeutic strategies.